Literature DB >> 20691407

Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems.

Stephen R Williams1, Micheala A Aldred, Vazken M Der Kaloustian, Fahed Halal, Gordon Gowans, D Ross McLeod, Sara Zondag, Helga V Toriello, R Ellen Magenis, Sarah H Elsea.   

Abstract

Brachydactyly mental retardation syndrome (BDMR) is associated with a deletion involving chromosome 2q37. BDMR presents with a range of features, including intellectual disabilities, developmental delays, behavioral abnormalities, sleep disturbance, craniofacial and skeletal abnormalities (including brachydactyly type E), and autism spectrum disorder. To date, only large deletions of 2q37 have been reported, making delineation of a critical region and subsequent identification of candidate genes difficult. We present clinical and molecular analysis of six individuals with overlapping deletions involving 2q37.3 that refine the critical region, reducing the candidate genes from >20 to a single gene, histone deacetylase 4 (HDAC4). Driven by the distinct hand and foot anomalies and similar cognitive features, we identified other cases with clinical findings consistent with BDMR but without a 2q37 deletion, and sequencing of HDAC4 identified de novo mutations, including one intragenic deletion probably disrupting normal splicing and one intragenic insertion that results in a frameshift and premature stop codon. HDAC4 is a histone deacetylase that regulates genes important in bone, muscle, neurological, and cardiac development. Reportedly, Hdac4(-/-) mice have severe bone malformations resulting from premature ossification of developing bones. Data presented here show that deletion or mutation of HDAC4 results in reduced expression of RAI1, which causes Smith-Magenis syndrome when haploinsufficient, providing a link to the overlapping findings in these disorders. Considering the known molecular function of HDAC4 and the mouse knockout phenotype, taken together with deletion or mutation of HDAC4 in multiple subjects with BDMR, we conclude that haploinsufficiency of HDAC4 results in brachydactyly mental retardation syndrome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20691407      PMCID: PMC2917703          DOI: 10.1016/j.ajhg.2010.07.011

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR.

Authors:  Wolfgang Fischle; Franck Dequiedt; Michael J Hendzel; Matthew G Guenther; Mitchell A Lazar; Wolfgang Voelter; Eric Verdin
Journal:  Mol Cell       Date:  2002-01       Impact factor: 17.970

2.  Molecular analysis of 20 patients with 2q37.3 monosomy: definition of minimum deletion intervals for key phenotypes.

Authors:  M A Aldred; R O C Sanford; N S Thomas; M A Barrow; L C Wilson; L A Brueton; M C Bonaglia; R C M Hennekam; C Eng; N R Dennis; R C Trembath
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

3.  Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice.

Authors:  S Takeda; J P Bonnamy; M J Owen; P Ducy; G Karsenty
Journal:  Genes Dev       Date:  2001-02-15       Impact factor: 11.361

4.  Albright hereditary osteodystrophy and del(2) (q37.3) in four unrelated individuals.

Authors:  M C Phelan; R C Rogers; K B Clarkson; F P Bowyer; M A Levine; L L Estabrooks; M C Severson; W B Dobyns
Journal:  Am J Med Genet       Date:  1995-07-31

Review 5.  MEF2: a calcium-dependent regulator of cell division, differentiation and death.

Authors:  Timothy A McKinsey; Chun Li Zhang; Eric N Olson
Journal:  Trends Biochem Sci       Date:  2002-01       Impact factor: 13.807

6.  Molecular genetic delineation of 2q37.3 deletion in autism and osteodystrophy: report of a case and of new markers for deletion screening by PCR.

Authors:  M Smith; J R Escamilla; P Filipek; M E Bocian; C Modahl; P Flodman; M A Spence
Journal:  Cytogenet Cell Genet       Date:  2001

7.  A functional network module for Smith-Magenis syndrome.

Authors:  S Girirajan; H T Truong; C L Blanchard; S H Elsea
Journal:  Clin Genet       Date:  2009-02-19       Impact factor: 4.438

8.  Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy.

Authors:  Chun Li Zhang; Timothy A McKinsey; Shurong Chang; Christopher L Antos; Joseph A Hill; Eric N Olson
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

9.  Brachydactyly and mental retardation: an Albright hereditary osteodystrophy-like syndrome localized to 2q37.

Authors:  L C Wilson; K Leverton; M E Oude Luttikhuis; C A Oley; J Flint; J Wolstenholme; D P Duckett; M A Barrow; J V Leonard; A P Read
Journal:  Am J Hum Genet       Date:  1995-02       Impact factor: 11.025

10.  Pilot assessment of the subtelomeric regions of children with autism: detection of a 2q deletion.

Authors:  Daynna J Wolff; Kimberly Clifton; Cynthia Karr; Jane Charles
Journal:  Genet Med       Date:  2002 Jan-Feb       Impact factor: 8.822

View more
  118 in total

1.  Regulation of neuronal gene expression and survival by basal NMDA receptor activity: a role for histone deacetylase 4.

Authors:  Yelin Chen; Yuanyuan Wang; Zora Modrusan; Morgan Sheng; Joshua S Kaminker
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

Review 2.  Hdac-mediated control of endochondral and intramembranous ossification.

Authors:  Elizabeth W Bradley; Meghan E McGee-Lawrence; Jennifer J Westendorf
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

Review 3.  Genetic variation in the epigenetic machinery and mental health.

Authors:  Chris Murgatroyd; Dietmar Spengler
Journal:  Curr Psychiatry Rep       Date:  2012-04       Impact factor: 5.285

Review 4.  Epigenetic protein families: a new frontier for drug discovery.

Authors:  Cheryl H Arrowsmith; Chas Bountra; Paul V Fish; Kevin Lee; Matthieu Schapira
Journal:  Nat Rev Drug Discov       Date:  2012-04-13       Impact factor: 84.694

Review 5.  Nuclear receptor coregulators: modulators of pathology and therapeutic targets.

Authors:  David M Lonard; Bert W O'Malley
Journal:  Nat Rev Endocrinol       Date:  2012-06-26       Impact factor: 43.330

Review 6.  Histone Deacetylases in Bone Development and Skeletal Disorders.

Authors:  Elizabeth W Bradley; Lomeli R Carpio; Andre J van Wijnen; Meghan E McGee-Lawrence; Jennifer J Westendorf
Journal:  Physiol Rev       Date:  2015-10       Impact factor: 37.312

7.  Fine mapping of bone structure and strength QTLs in heterogeneous stock rat.

Authors:  Imranul Alam; Daniel L Koller; Toni Cañete; Gloria Blázquez; Carme Mont-Cardona; Regina López-Aumatell; Esther Martínez-Membrives; Sira Díaz-Morán; Adolf Tobeña; Alberto Fernández-Teruel; Pernilla Stridh; Margarita Diez; Tomas Olsson; Martina Johannesson; Amelie Baud; Michael J Econs; Tatiana Foroud
Journal:  Bone       Date:  2015-08-19       Impact factor: 4.398

Review 8.  Advances in Skeletal Dysplasia Genetics.

Authors:  Krista A Geister; Sally A Camper
Journal:  Annu Rev Genomics Hum Genet       Date:  2015-04-22       Impact factor: 8.929

Review 9.  Neural crest contributions to the ear: Implications for congenital hearing disorders.

Authors:  K Elaine Ritter; Donna M Martin
Journal:  Hear Res       Date:  2018-11-14       Impact factor: 3.208

10.  A Heterozygous Splice-Site Mutation in PTHLH Causes Autosomal Dominant Shortening of Metacarpals and Metatarsals.

Authors:  Monica Reyes; Bert Bravenboer; Harald Jüppner
Journal:  J Bone Miner Res       Date:  2019-01-02       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.